198 related articles for article (PubMed ID: 22907255)
1. Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer.
Lin YC; Mahalingam J; Chiang JM; Su PJ; Chu YY; Lai HY; Fang JH; Huang CT; Chiu CT; Lin CY
Int J Cancer; 2013 Mar; 132(6):1341-50. PubMed ID: 22907255
[TBL] [Abstract][Full Text] [Related]
2. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis.
Matsuki F; Saegusa J; Miyamoto Y; Misaki K; Kumagai S; Morinobu A
Biochem Biophys Res Commun; 2013 Sep; 438(4):778-83. PubMed ID: 23747721
[TBL] [Abstract][Full Text] [Related]
3. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
4. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
Frey DM; Droeser RA; Viehl CT; Zlobec I; Lugli A; Zingg U; Oertli D; Kettelhack C; Terracciano L; Tornillo L
Int J Cancer; 2010 Jun; 126(11):2635-43. PubMed ID: 19856313
[TBL] [Abstract][Full Text] [Related]
5. Functionally distinct subsets of CD4⁺ regulatory T cells in patients with laryngeal squamous cell carcinoma are indicative of immune deregulation and disease progression.
Sun W; Li WJ; Fu QL; Wu CY; Lin JZ; Zhu XL; Hou WJ; Wei Y; Wen YH; Wang YJ; Wen WP
Oncol Rep; 2015 Jan; 33(1):354-62. PubMed ID: 25333227
[TBL] [Abstract][Full Text] [Related]
6. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
[TBL] [Abstract][Full Text] [Related]
7. Tumor infiltration by T lymphocytes expressing chemokine receptor 7 (CCR7) is predictive of favorable outcome in patients with advanced colorectal carcinoma.
Correale P; Rotundo MS; Botta C; Del Vecchio MT; Ginanneschi C; Licchetta A; Conca R; Apollinari S; De Luca F; Tassone P; Tagliaferri P
Clin Cancer Res; 2012 Feb; 18(3):850-7. PubMed ID: 22142823
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC
J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750
[TBL] [Abstract][Full Text] [Related]
9. Role of LAP
Zhong W; Jiang ZY; Zhang L; Huang JH; Wang SJ; Liao C; Cai B; Chen LS; Zhang S; Guo Y; Cao YF; Gao F
World J Gastroenterol; 2017 Jan; 23(3):455-463. PubMed ID: 28210081
[TBL] [Abstract][Full Text] [Related]
10. Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.
Anichini A; Molla A; Vegetti C; Bersani I; Zappasodi R; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Pircher H; Di Nicola M; Mortarini R
Cancer Res; 2010 Nov; 70(21):8378-87. PubMed ID: 20861189
[TBL] [Abstract][Full Text] [Related]
11. Human epithelial ovarian carcinoma cell-derived cytokines cooperatively induce activated CD4+CD25-CD45RA+ naïve T cells to express forkhead box protein 3 and exhibit suppressive ability in vitro.
Zhao X; Ye F; Chen L; Lu W; Xie X
Cancer Sci; 2009 Nov; 100(11):2143-51. PubMed ID: 19673890
[TBL] [Abstract][Full Text] [Related]
12. High frequency of regulatory T cells among HIV type 1-infected men who have sex with men correlates with disease progression.
Wang WH; Ming L; Wang Y; Kan QC; Zhang XY
Chin Med J (Engl); 2013; 126(11):2054-61. PubMed ID: 23769557
[TBL] [Abstract][Full Text] [Related]
13. Increased tumor-infiltrating CD45RA
Mao FY; Kong H; Zhao YL; Peng LS; Chen W; Zhang JY; Cheng P; Wang TT; Lv YP; Teng YS; Fu XL; Liu YG; Wu XL; Hao CJ; You N; Luo P; Yu PW; Zou QM; Guo G; Zhuang Y
Cell Death Dis; 2017 Aug; 8(8):e3002. PubMed ID: 28817117
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype.
Barnett JC; Bean SM; Whitaker RS; Kondoh E; Baba T; Fujii S; Marks JR; Dressman HK; Murphy SK; Berchuck A
Gynecol Oncol; 2010 Mar; 116(3):556-62. PubMed ID: 20006900
[TBL] [Abstract][Full Text] [Related]
15. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells.
Seddiki N; Santner-Nanan B; Martinson J; Zaunders J; Sasson S; Landay A; Solomon M; Selby W; Alexander SI; Nanan R; Kelleher A; Fazekas de St Groth B
J Exp Med; 2006 Jul; 203(7):1693-700. PubMed ID: 16818676
[TBL] [Abstract][Full Text] [Related]
16. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
17. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.
Yang ZQ; Yang ZY; Zhang LD; Ping-Bie ; Wang SG; Ma KS; Li XW; Dong JH
Hum Immunol; 2010 Dec; 71(12):1180-6. PubMed ID: 20870003
[TBL] [Abstract][Full Text] [Related]
18. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.
Miyara M; Yoshioka Y; Kitoh A; Shima T; Wing K; Niwa A; Parizot C; Taflin C; Heike T; Valeyre D; Mathian A; Nakahata T; Yamaguchi T; Nomura T; Ono M; Amoura Z; Gorochov G; Sakaguchi S
Immunity; 2009 Jun; 30(6):899-911. PubMed ID: 19464196
[TBL] [Abstract][Full Text] [Related]
19. LAP+CD4+ T cells are suppressors accumulated in the tumor sites and associated with the progression of colorectal cancer.
Mahalingam J; Lin YC; Chiang JM; Su PJ; Fang JH; Chu YY; Huang CT; Chiu CT; Lin CY
Clin Cancer Res; 2012 Oct; 18(19):5224-33. PubMed ID: 22879386
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.
Chang LY; Lin YC; Mahalingam J; Huang CT; Chen TW; Kang CW; Peng HM; Chu YY; Chiang JM; Dutta A; Day YJ; Chen TC; Yeh CT; Lin CY
Cancer Res; 2012 Mar; 72(5):1092-102. PubMed ID: 22282655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]